Opinion|Videos|April 25, 2025
Closing Perspectives
Experts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you evaluate the cost-effectiveness of CGM compared to traditional monitoring when considering both clinical and quality outcomes?
- What: combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5